TABLE 2.
Primers used in this study
Primer | Sequence (5′-3′)a |
---|---|
MEP3 | TAAATACGGTACCCAAACGATTGGCTTGAATGTC |
MEP9 | CCATGAGTTGAGATCTCAGTATCATTGTG |
MEP23 | AGAAATCAGATCTACACTTCAACGTAATCATAAGC |
MEP32 | AAAGAACTGGATCCATTTTTAGCTTCTCC |
MEP38p | CCGGCGAACAACAATGCACCTAAGC |
MEP39p | TGGCGGTCCAGTTCACGAAAACTCTGG |
MEP59 | CAGCATAATAGATCTTATTCACCAATTTGGG |
MEP67p | CCGGCGAAATTCAATGCACCTAAGC |
MEP68p | CAGCAGCAAACATCCCTTGGGCAAGACAGAAC |
MEP69p | CAGCAGCAGCCATCCCTTGGTAAAGACAGAAC |
MEP70p | TCACTGCTATTTTGATGGCTGGTGC |
MEP71p | CCGGCGAAATCCAATGCACCTAAGC |
MEP72p | TGGCGGTCCAGTTGCCGAAAACTCTGG |
MEP73p | ACAGTAAACAACAGTCAACCAG |
MEP74p | CCTATTGCCTATGCCACATGGGGTGG |
MEP75p | GGCCCCACCGTTGAAACCGTACC |
MEP76p | ACTGGTAACTCTTCCATGCGTTC |
MEP77p | GTCCATACCATCATCAATCTGC |
MEP78p | GTGTGGGCACTCGCTGGTGTTGGTGG |
MEP80p | CCTATTGCCTATTGGACAGCCGGTGGAAATGG |
MEP81 | TTGGTTTCAGATCTAGTCATCAGCATAATAGG |
MEP82 | TTGGTTTCAAGATCTAATCAGCATAATAGG |
MEP83 | TTGGTTTCAGGATAGATCTAAGCATAATAGGCATATTCACC |
MEP84 | TTCAGGATCGTAGATCTAATAATAGGCATATTCACC |
MEP85 | TTCAGGATCGTCATCAGATCTAATAGGCATATTCACC |
MEP86 | ATCGTCATCAGCAGATCTAGGCATATTCACCAATTTGG |
MEP87 | ATCGTCATCAGCATAGATCTAATATTCACCAATTTGGG |
MEP91 | TCACTTCAAAGATCTAATAAGCAAATTCACCAATTTG |
MEP94p | GGACCCACCGTTGGCACCGTACCAACC |
MEP95 | ATTTAGATCTAATAGGCAAATTCACCAATTTG |
MEP96 | ATTTAGATCTAATAGGCATATTCACCAATTTGATCCAAGTCGGTTCC |
MEP97 | ATTTAGATCTAATAGGCATATTCACCAATTTGGGCTTCGTCGGTTCC |
MEP98 | ATTTAGATCTAATAGGCATATTCACCAATTTGGGCCAAGTCAACTCCCAACATTTC |
MEP99 | ATTTAGATCTAATAGGCATATTCACCAATTTGGGCCAAGTCGGTTCCAGCCATTTCCTCGTC |
MEP100 | ATTTAGATCTAATAGGCATATTCACCAATTTGGGCCAAGTCGGTTCCCAATTCTTCCTCGTCTTC |
MEP101 | ATTTAGATCTAATAGGCATATTCACCAATTTGGGCCAAGTCGGTTCCCAACATTTCTCCGTCTTCGTGGAG |
MEP102 | ATTTAGATCTAATAGGCATATTCACCAATTTGGGCCAAGTCGGTTCCCAACATTTCCTCATTTTCGTGGAGACG |
Restriction sites introduced into the primers are underlined; stop codons (reverse sequence) are highlighted in bold, and mutated codons are shown in italics. Primers with the suffix “-p” are 5′ phosphorylated.